The U.S. Preventative Services Task Force has postponed its November meeting due to the federal government shutdown.
FDA announced six additional awardees under the Commissioner’s National Priority Voucher pilot program, which aims to accelerate review time for applications that are deemed to be advancing U.S. “national priorities” (The Cancer Letter, Oct. 24, June 20, 2025).
The American Academy of Pediatrics does not recommend the routine use of leucovorin (folinic acid) for autistic children, according to the interim guidance issued by the physician group Oct. 31.
The White House Nov. 6 announced a deal with drugmakers Eli Lilly and Co. and Novo Nordisk to expand coverage and reduce prices for their obesity treatments, Zepbound and Wegovy.
Omar Abdel-WahabAndrea AblasserChristina CurtisOmar Abdel-Wahab, Andrea Ablasser, and Christina Curtis were named awardees of the 2025 Memorial Sloan Kettering Cancer Center Paul Marks Prize for Cancer Research.
James S. Hu was named associate director of the Sarcoma Program at Cedars-Sinai Cancer.
The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies.
The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research, and training
Azeddine AtfiElizabeth CunninghamBenjamin HerringThe Barbara Ann Karmanos Cancer Institute has appointed Azeddine Atfi as deputy center director of research, Elizabeth Cunningham as vice president of the Karmanos Cancer Institute Clinical Trials Office, and Benjamin Herring as vice president and associate center director of research administration.
Paige Aiello has joined The Barbara Ann Karmanos Cancer Institute as a breast surgeon and member of the Breast Cancer Multidisciplinary Team.
